Long-tao Z. Yue
Jinan 250014, PR China
Puerto Rico
Puerto Rico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Loganetin Induces AML Cell Differentiation and Chromosomal Instability via KLHL6-Mediated CDK2 Ubiquitination Degradation
Journal: Zhongguo shi yan xue ye xue za zhi
Published: June 02, 2026
Correction to: Exosomes derived from atorvastatin-modified bone marrow dendritic cells ameliorate experimental autoimmune myasthenia gravis by up-regulated levels of IDO/Treg and partly dependent on FasL/Fas pathway.
Journal: Journal of neuroinflammation
Published: June 07, 2019
Corrigendum to: "low and high doses of ursolic acid ameliorate experimental autoimmune myasthenia gravis through different pathways" [Journal of Neuroimmunology 281 (2015) 61-67].
Journal: Journal of neuroimmunology
Published: April 02, 2019
Toll-like receptor 9 antagonist suppresses humoral immunity in experimental autoimmune myasthenia gravis.
Journal: Molecular immunology
Published: October 11, 2017
Enhanced glycolysis contributes to the pathogenesis of experimental autoimmune neuritis.
Journal: Journal of neuroinflammation
Published: September 28, 2017
ONX-0914, a selective inhibitor of immunoproteasome, ameliorates experimental autoimmune myasthenia gravis by modulating humoral response.
Journal: Journal of neuroimmunology
Published: May 03, 2017
Statins reduce the expressions of Tim-3 on NK cells and NKT cells in atherosclerosis.
Journal: European journal of pharmacology
Published: May 01, 2017
Parthenolide inhibits the initiation of experimental autoimmune neuritis.
Journal: Journal of neuroimmunology
Published: December 01, 2016
Caspase-1 inhibitor regulates humoral responses in experimental autoimmune myasthenia gravis via IL-6- dependent inhibiton of STAT3.
Journal: Neuroscience letters
Published: October 30, 2016
Curcumin ameliorates experimental autoimmune myasthenia gravis by diverse immune cells.
Journal: Neuroscience letters
Published: April 06, 2016
Astilbin ameliorates experimental autoimmune myasthenia gravis by decreased Th17 cytokines and up-regulated T regulatory cells.
Journal: Journal of neuroimmunology
Published: April 03, 2016
Activation of the adenosine A2A receptor exacerbates experimental autoimmune neuritis in Lewis rats in association with enhanced humoral immunity.
Journal: Journal of neuroimmunology
Published: September 20, 2015
Last Updated: 09/26/2026